FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Beverage

  • Home
  •  | 
  • Tag Archives: "Beverage"

Isodiol International Inc. & Brew Hub, LLC Announce Agreement for the Development of Hemp Beer and Related Functional Beverages

Isodiol International Inc. & Brew Hub, LLC Announce Agreement for the Development of Hemp Beer and Related Functional Beverages
Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F)(the “Company” or “Isodiol”) announced today that its wholly owned subsidiary, IsoBev International Inc. (“IsoBev”), has executed an agreement with Brew Hub, LLC (“Brew Hub”) for the exclusive development and manufacturing of hemp, cannabis, hemp-derived, and cannabis-derived beverages in what the companies believe is among the most significant alternative beverage deals in the industry.
Read more

CROP to Infuse its ‘CannaDrink’ Functional Beverage With Naturally Splendid’s HempOmega™

CROP to Infuse its ‘CannaDrink’ Functional Beverage With Naturally Splendid’s HempOmega™
HempOmega™ is a unique and proprietary homogenous powder created from microencapsulated hemp seed oil. It is a high-quality and sustainable omega fatty acid alternative ingredient. Due to its unique powder format, it solves the formulation challenge manufacturers face when trying to add oil to existing products and has proven to increase the bioavailability of omega fatty acids. The global carbonated soft drinks market is projected to reach USD 605.6 billion by 2025, according to a March 2018 report by Grand View Research, Inc.
Read more

Breaking News – DEA Removes CBD as a Schedule 1 Drug. CBD Stocks to Watch – GW Pharma, India Globalization Capital, Inc., Tilray Inc, American Premium Water Corp

Breaking News – DEA Removes CBD as a Schedule 1 Drug. CBD Stocks to Watch – GW Pharma, India Globalization Capital, Inc., Tilray Inc, American Premium Water Corp
This news sent several CBD stocks moving to the upside including Tilray Inc, also making inroads into Pharma. On September 18th the company announced that “the U.S. Drug Enforcement Administration (DEA) has granted approval to import a cannabinoid study drug into the United States from Canada for a clinical trial at the University of California San Diego (UC San Diego) Center for Medicinal Cannabis Research (CMCR) examining its safety, tolerability and efficacy for Essential Tremor (ET).”
Read more